Compare $KYNB vs $SHPH | Chartloom

Compare

$KYNB vs $SHPH

Kyntra Bio Inc · Shuttle Pharmaceuticals Holdings Inc

KYNB

Kyntra Bio Inc

SHPH

Shuttle Pharmaceuticals Holdings Inc

Compare $KYNB vs $SHPH

Comparing Kyntra Bio Inc and Shuttle Pharmaceuticals Holdings Inc

KYNBKyntra Bio Inc

SHPHShuttle Pharmaceuticals Holdings Inc

KYNBKyntra Bio Inc

Market cap

$25M

P/E (TTM)

0.14x

Forward P/E (NTM)

—

Forward P/S (NTM)

3.52x

Rev growth (TTM)

-91.4%

YTD performance

-33.3%

52W performance

-46.4%

FCF yield

-153.8%

SHPHShuttle Pharmaceuticals Holdings Inc

Market cap

$3M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-70.6%

52W performance

-87.9%

FCF yield

-283.7%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

KYNB

SHPH

Detailed metrics comparison

KYNB

Kyntra Bio Inc

SHPH

Shuttle Pharmaceuticals Holdings Inc

Market Cap

KYNB$25M

SHPH$3M

Enterprise Value

KYNB$-26M

SHPH$3M

Price

KYNB$6.11

SHPH$5.33

P/E Ratio

KYNB0.14x

SHPHN/A

P/S Ratio

KYNB5.36x

SHPH0.00x

EV/Sales

KYNB-5.61x

SHPH0.00x

EV/EBITDA

KYNB0.00x

SHPH0.00x

P/B Ratio

KYNB0.97x

SHPH5.94x

P/FCF Ratio

KYNBN/A

SHPHN/A

EV/FCF

KYNB0.68x

SHPH-0.34x

PEG Ratio

KYNBN/A

SHPHN/A

Forward P/E (NTM)

KYNBN/A

SHPHN/A

Forward P/S (NTM)

KYNB3.52x

SHPHN/A

Revenue (TTM)

KYNB$5M

SHPH$0

Revenue Growth (YoY)

KYNB-91.4%

SHPHN/A

Forward Rev Growth

KYNB21.6%

SHPH0.0%

Gross Margin (TTM)

KYNB6.3%

SHPH0.0%

Operating Margin (TTM)

KYNB0.0%

SHPH0.0%

EBITDA Margin (TTM)

KYNB-1083.7%

SHPH0.0%

Net Margin (TTM)

KYNB3967.8%

SHPH0.0%

FCF Margin (TTM)

KYNB-824.4%

SHPHN/A

Net Income (TTM)

KYNB$183M

SHPH$-10M

FCF (TTM)

KYNB$-38M

SHPH$-10M

EPS (TTM)

KYNB$45.25

SHPH-$10.11

ROE (TTM)

KYNB-29091.0%

SHPH-40833.0%

ROA (TTM)

KYNB156.8%

SHPH-13815.0%

ROIC (TTM)

KYNB-25645.0%

SHPH-37757.0%

Cash

KYNB$51M

SHPH$90K

Debt

KYNB$0

SHPH$0

Net Cash/Debt

KYNB$51M

SHPH$90K

Current Ratio (TTM)

KYNB2.69x

SHPH0.30x

Quick Ratio (TTM)

KYNB2.57x

SHPH0.13x

Debt/Equity (TTM)

KYNB0.59x

SHPH1.23x

Debt/Assets (TTM)

KYNB0.0%

SHPH0.0%

Interest Coverage (TTM)

KYNBN/A

SHPHN/A

Net Debt/EBITDA (TTM)

KYNB0.00x

SHPH0.00x

Beta

KYNB1.07

SHPH1.13

52W Performance

KYNB-46.4%

SHPH-87.9%

YTD Performance

KYNB-33.3%

SHPH-70.6%

% from 52W High

KYNB-47.6%

SHPH-90.5%

% from 52W Low

KYNB8.7%

SHPH106.9%

Asset Turnover (TTM)

KYNB0.05x

SHPH0.00x

FCF Yield (TTM)

KYNB-153.8%

SHPH-283.7%

Earnings Yield (TTM)

KYNB740.3%

SHPH-300.8%

Dividend Yield (TTM)

KYNBN/A

SHPHN/A

Rule of 40

KYNB-915.8

SHPH0.0

EV/GP/RG

KYNBN/A

SHPHN/A

Ticker research

View KYNB research View SHPH research

Metric	KYNB Kyntra Bio Inc	SHPH Shuttle Pharmaceuticals Holdings Inc
Market & Valuation
Market Cap	$25M	$3M
Enterprise Value	$-26M	$3M
Price	$6.11	$5.33
P/E Ratio	0.14x	N/A
P/S Ratio	5.36x	0.00x
EV/Sales	-5.61x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.97x	5.94x
P/FCF Ratio	N/A	N/A
EV/FCF	0.68x	-0.34x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	3.52x	N/A
Revenue & Growth
Revenue (TTM)	$5M	$0
Revenue Growth (YoY)	-91.4%	N/A
Forward Rev Growth	21.6%	0.0%
Profitability
Gross Margin (TTM)	6.3%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-1083.7%	0.0%
Net Margin (TTM)	3967.8%	0.0%
FCF Margin (TTM)	-824.4%	N/A
Net Income (TTM)	$183M	$-10M
FCF (TTM)	$-38M	$-10M
EPS (TTM)	$45.25	-$10.11
ROE (TTM)	-29091.0%	-40833.0%
ROA (TTM)	156.8%	-13815.0%
ROIC (TTM)	-25645.0%	-37757.0%
Financial Health
Cash	$51M	$90K
Debt	$0	$0
Net Cash/Debt	$51M	$90K
Current Ratio (TTM)	2.69x	0.30x
Quick Ratio (TTM)	2.57x	0.13x
Debt/Equity (TTM)	0.59x	1.23x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.07	1.13
52W Performance	-46.4%	-87.9%
YTD Performance	-33.3%	-70.6%
% from 52W High	-47.6%	-90.5%
% from 52W Low	8.7%	106.9%
Efficiency & Yields
Asset Turnover (TTM)	0.05x	0.00x
FCF Yield (TTM)	-153.8%	-283.7%
Earnings Yield (TTM)	740.3%	-300.8%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-915.8	0.0
EV/GP/RG	N/A	N/A
Ticker research	View KYNB research	View SHPH research

Valuation

P/E Ratio

KYNB

0.14x

P/S Ratio

SHPH

0.00x

KYNB

5.36x

EV/FCF

SHPH

-0.34x

KYNB

0.68x

Growth & revenue

Revenue Growth TTM

KYNB

-91.4%

Forward Revenue Growth

KYNB

21.6%

SHPH

0.0%

Profitability & performance

Gross Margin

KYNB

6.3%

SHPH

0.0%

ROE

KYNB

-29091.0%

SHPH

-40833.0%

FCF Yield %

KYNB

-153.8%

SHPH

-283.7%

52-Week Performance

KYNB

-46.4%

SHPH

-87.9%

Detailed metrics comparison

KYNB

Kyntra Bio Inc

SHPH

Shuttle Pharmaceuticals Holdings Inc

Market Cap

KYNB$25M

SHPH$3M

Enterprise Value

KYNB$-26M

SHPH$3M

Price

KYNB$6.11

SHPH$5.33

P/E Ratio

KYNB0.14x

SHPHN/A

P/S Ratio

KYNB5.36x

SHPH0.00x

EV/Sales

KYNB-5.61x

SHPH0.00x

EV/EBITDA

KYNB0.00x

SHPH0.00x

P/B Ratio

KYNB0.97x

SHPH5.94x

P/FCF Ratio

KYNBN/A

SHPHN/A

EV/FCF

KYNB0.68x

SHPH-0.34x

PEG Ratio

KYNBN/A

SHPHN/A

Forward P/E (NTM)

KYNBN/A

SHPHN/A

Forward P/S (NTM)

KYNB3.52x

SHPHN/A

Revenue (TTM)

KYNB$5M

SHPH$0

Revenue Growth (YoY)

KYNB-91.4%

SHPHN/A

Forward Rev Growth

KYNB21.6%

SHPH0.0%

Gross Margin (TTM)

KYNB6.3%

SHPH0.0%

Operating Margin (TTM)

KYNB0.0%

SHPH0.0%

EBITDA Margin (TTM)

KYNB-1083.7%

SHPH0.0%

Net Margin (TTM)

KYNB3967.8%

SHPH0.0%

FCF Margin (TTM)

KYNB-824.4%

SHPHN/A

Net Income (TTM)

KYNB$183M

SHPH$-10M

FCF (TTM)

KYNB$-38M

SHPH$-10M

EPS (TTM)

KYNB$45.25

SHPH-$10.11

ROE (TTM)

KYNB-29091.0%

SHPH-40833.0%

ROA (TTM)

KYNB156.8%

SHPH-13815.0%

ROIC (TTM)

KYNB-25645.0%

SHPH-37757.0%

Cash

KYNB$51M

SHPH$90K

Debt

KYNB$0

SHPH$0

Net Cash/Debt

KYNB$51M

SHPH$90K

Current Ratio (TTM)

KYNB2.69x

SHPH0.30x

Quick Ratio (TTM)

KYNB2.57x

SHPH0.13x

Debt/Equity (TTM)

KYNB0.59x

SHPH1.23x

Debt/Assets (TTM)

KYNB0.0%

SHPH0.0%

Interest Coverage (TTM)

KYNBN/A

SHPHN/A

Net Debt/EBITDA (TTM)

KYNB0.00x

SHPH0.00x

Beta

KYNB1.07

SHPH1.13

52W Performance

KYNB-46.4%

SHPH-87.9%

YTD Performance

KYNB-33.3%

SHPH-70.6%

% from 52W High

KYNB-47.6%

SHPH-90.5%

% from 52W Low

KYNB8.7%

SHPH106.9%

Asset Turnover (TTM)

KYNB0.05x

SHPH0.00x

FCF Yield (TTM)

KYNB-153.8%

SHPH-283.7%

Earnings Yield (TTM)

KYNB740.3%

SHPH-300.8%

Dividend Yield (TTM)

KYNBN/A

SHPHN/A

Rule of 40

KYNB-915.8

SHPH0.0

EV/GP/RG

KYNBN/A

SHPHN/A

Ticker research

View KYNB research View SHPH research

Metric	KYNB Kyntra Bio Inc	SHPH Shuttle Pharmaceuticals Holdings Inc
Market & Valuation
Market Cap	$25M	$3M
Enterprise Value	$-26M	$3M
Price	$6.11	$5.33
P/E Ratio	0.14x	N/A
P/S Ratio	5.36x	0.00x
EV/Sales	-5.61x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.97x	5.94x
P/FCF Ratio	N/A	N/A
EV/FCF	0.68x	-0.34x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	3.52x	N/A
Revenue & Growth
Revenue (TTM)	$5M	$0
Revenue Growth (YoY)	-91.4%	N/A
Forward Rev Growth	21.6%	0.0%
Profitability
Gross Margin (TTM)	6.3%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-1083.7%	0.0%
Net Margin (TTM)	3967.8%	0.0%
FCF Margin (TTM)	-824.4%	N/A
Net Income (TTM)	$183M	$-10M
FCF (TTM)	$-38M	$-10M
EPS (TTM)	$45.25	-$10.11
ROE (TTM)	-29091.0%	-40833.0%
ROA (TTM)	156.8%	-13815.0%
ROIC (TTM)	-25645.0%	-37757.0%
Financial Health
Cash	$51M	$90K
Debt	$0	$0
Net Cash/Debt	$51M	$90K
Current Ratio (TTM)	2.69x	0.30x
Quick Ratio (TTM)	2.57x	0.13x
Debt/Equity (TTM)	0.59x	1.23x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.07	1.13
52W Performance	-46.4%	-87.9%
YTD Performance	-33.3%	-70.6%
% from 52W High	-47.6%	-90.5%
% from 52W Low	8.7%	106.9%
Efficiency & Yields
Asset Turnover (TTM)	0.05x	0.00x
FCF Yield (TTM)	-153.8%	-283.7%
Earnings Yield (TTM)	740.3%	-300.8%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-915.8	0.0
EV/GP/RG	N/A	N/A
Ticker research	View KYNB research	View SHPH research